Literature DB >> 23190883

Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.

Sophie C Flohil1, Inge Seubring, Michelle M van Rossum, Jan-Willem W Coebergh, Esther de Vries, Tamar Nijsten.   

Abstract

Basal cell carcinoma (BCC) incidence rates are increasing. From 1973 to 2009, data on all first histologically confirmed BCCs were gained from the Eindhoven Cancer Registry to estimate trends in patient-based BCC incidence rates by sex, age group, and site in the southeast Netherlands. Trends in European age-standardized rates and age- and site-specific incidence rates were assessed by calculating the estimated annual percentage change (EAPC). Between 1973 and 2009, the European standardized rate quadrupled from 40 to 165 per 100,000 person-years for men and from 34 to 157 for women, significantly increasing since 1973 in both sexes, but accelerating from 2002 until 2009 with an EAPC of 6.8% (95% confidence interval (CI), 5.3-8.3) for men and 7.9% (95% CI, 6.2-9.7) for women. Women below the age of 40 years exhibited a constant linear increase of 6.3% since 1973. The head and neck region was most often affected in both sexes, but the steepest increase was seen for the trunk (EAPC men 13%, women 15%). In the absence of reliable tumor-based rates, these alarming patient-based rates are probably an interesting indicator for the impact of more intensive UV exposure in a prosperous European population.

Entities:  

Mesh:

Year:  2012        PMID: 23190883     DOI: 10.1038/jid.2012.431

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  39 in total

1.  The invisible basal cell carcinoma: how reflectance confocal microscopy improves the diagnostic accuracy of clinically unclear facial macules and papules.

Authors:  C Ruini; D Hartmann; S Saral; S Krammer; T Ruzicka; T von Braunmühl
Journal:  Lasers Med Sci       Date:  2016-08-04       Impact factor: 3.161

2.  Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010.

Authors:  John G Muzic; Adam R Schmitt; Adam C Wright; Dema T Alniemi; Adeel S Zubair; Jeannette M Olazagasti Lourido; Ivette M Sosa Seda; Amy L Weaver; Christian L Baum
Journal:  Mayo Clin Proc       Date:  2017-05-15       Impact factor: 7.616

3.  Predicting the Risk of a Second Basal Cell Carcinoma.

Authors:  Joris A C Verkouteren; Hilde Smedinga; Ewout W Steyerberg; Albert Hofman; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2015-03-03       Impact factor: 8.551

4.  YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.

Authors:  Dejan Maglic; Karin Schlegelmilch; Antonella Fm Dost; Riccardo Panero; Michael T Dill; Raffaele A Calogero; Fernando D Camargo
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

5.  Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case-Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors.

Authors:  Mohammad-Ali Yazdani Abyaneh; Peter Engel; Andrzej Slominski; Bruce Ragsdale; Richard Agag; Daniel Cramer; J Andrew Carlson
Journal:  Am J Dermatopathol       Date:  2017-03       Impact factor: 1.533

6.  Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence.

Authors:  Nora Eisemann; Annika Waldmann; Alan C Geller; Martin A Weinstock; Beate Volkmer; Ruediger Greinert; Eckhard W Breitbart; Alexander Katalinic
Journal:  J Invest Dermatol       Date:  2013-07-22       Impact factor: 8.551

7.  Sex hormones and the risk of keratinocyte cancers among women in the United States: A population-based case-control study.

Authors:  Lawrence F Kuklinski; Michael S Zens; Ann E Perry; Anala Gossai; Heather H Nelson; Margaret R Karagas
Journal:  Int J Cancer       Date:  2016-04-15       Impact factor: 7.396

8.  Differences in Rate of Complete Excision of Basal Cell Carcinoma by Dermatologists, Plastic Surgeons and General Practitioners: A Large Cross-Sectional Study.

Authors:  Kirtie Ramdas; Charlotte van Lee; Samuel Beck; Patrick Bindels; Vincent Noordhoek Hegt; Luba Pardo; Sarah Versnel; Tamar Nijsten; Renate van den Bos
Journal:  Dermatology       Date:  2018-08-07       Impact factor: 5.366

9.  Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.

Authors:  Sabrina Pricl; Barbara Cortelazzi; Valentina Dal Col; Domenico Marson; Erik Laurini; Maurizio Fermeglia; Lisa Licitra; Silvana Pilotti; Paolo Bossi; Federica Perrone
Journal:  Mol Oncol       Date:  2014-09-26       Impact factor: 6.603

10.  Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy.

Authors:  Orit Markowitz; Michelle Schwartz; Eleanor Feldman; Amanda Bienenfeld; Amy K Bieber; Jeffery Ellis; Usha Alapati; Mark Lebwohl; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.